Nisa Investment Advisors, LLC Kala Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$1.16 - $2.74 $3,129 - $7,392	-2,698 Reduced 72.66%	1,015 $1,000
Q3 2021 Oct 18, 2021	SELL	$2.62 - $5.43 $72,474 - $150,204	-27,662 Reduced 88.17%	3,713 $10,000
Q2 2021 Aug 06, 2021	SELL	$5.06 - $8.15 $29,347 - $47,270	-5,800 Reduced 15.6%	31,375 $166,000
Q4 2020 Jan 25, 2021	BUY	$6.28 - $8.79 $199,547 - $279,302	31,775 Added 588.43%	37,175 $252,000
Q2 2020 Jul 27, 2020	BUY	$8.33 - $13.79 $3,748 - $6,205	450 Added 9.09%	5,400 $57,000
Q1 2020 Apr 17, 2020	BUY	$3.83 - $8.79 $18,958 - $43,510	4,950 New	4,950 $44,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.74M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.